Science Explorer Back to mapMap
Discussion
Researcher · Instituto Gulbenkian de Ciência · Portugal

Jocelyne Demengeot

Jocelyne Demengeot publishes mostly in Immunology, Infectious Diseases and Molecular Biology, on topics such as T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

ORCID 0000-0002-4761-614X OpenAlex
World rank
#324,212
of 7,710,434 ranked researchers
Rank in Portugal
#931
of 41,760
Works
118
Citations
8.6k
Citations per work
72.6
h-index
41
i10-index 71Top 7.2% in Immunology
Jocelyne Demengeot

What does Jocelyne Demengeot research?

Jocelyne Demengeot's work is mostly in Immunology and Microbiology (47%), Medicine (16%), Biochemistry, Genetics and Molecular Biology (13%).

Life Sciences: 72 works · 60.7% of their workImmunology and Microbiology: 56 works · 47.3% of their workImmunology: 56 works · 47.3% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 13.4% of their workMolecular Biology: 10 works · 8.3% of their workGenetics: 6 works · 5.1% of their workEverything else: 28 works · 23.5% of their workHealth Sciences: 19 works · 15.8% of their workMedicine: 19 works · 15.8% of their workInfectious Diseases: 11 works · 8.9% of their workOncology: 4 works · 3.6% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 3.3% of their workTHEIR WORKJocelyneDemengeot118works
Life Sciences61%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology5647.3%
    2. Biochemistry, Genetics and Molecular Biology1613.4%
  2. Everything else2823.5%
    1. Medicine1915.8%
  1. 1Immunology47% of their works
  2. 2Infectious Diseases9% of their works
  3. 3Molecular Biology8% of their works
  4. 4Genetics5% of their works
  5. 5Oncology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Jocelyne Demengeot's research?

The keywords of their largest research topics: Autoimmunity, Foxp3, TGF-ß, Natural Killer Cells, NK Cell Recognition, Immunity, Cancer Immunotherapy and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Autoimmunity632 topics
  2. Foxp3531 topic
  3. TGF-ß531 topic
  4. NK Cell Recognition471 topic
  5. Natural Killer Cells471 topic
  6. Immunity382 topics
  7. Cancer Immunotherapy261 topic
  8. Dendritic Cells261 topic
  9. ACE2 Receptor202 topics
  10. SARS-CoV-2202 topics
  11. Epidemiology182 topics
  12. Genetic Mutations131 topic
  13. Primary Immunodeficiency131 topic
  14. Coronavirus121 topic
  15. Vaccine121 topic
  16. Fc Receptors111 topic
  17. Therapeutic Antibodies111 topic
  18. Genetics101 topic
  19. Type 1 Diabetes101 topic
  20. Clinical Characteristics81 topic
  21. Thrombosis81 topic

Where does Jocelyne Demengeot work?

Jocelyne Demengeot's main affiliation in the publication record is Instituto Gulbenkian de Ciência, Portugal.

How many publications and citations does Jocelyne Demengeot have?

OpenAlex counts 118 works and 8,570 citations for Jocelyne Demengeot, an h-index of 41, ranking #324,212 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jocelyne Demengeot. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.